These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surgical strategy for the treatment of medullary thyroid carcinoma. Fleming JB; Lee JE; Bouvet M; Schultz PN; Sherman SI; Sellin RV; Friend KE; Burgess MA; Cote GJ; Gagel RF; Evans DB Ann Surg; 1999 Nov; 230(5):697-707. PubMed ID: 10561095 [TBL] [Abstract][Full Text] [Related]
3. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience. Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924 [TBL] [Abstract][Full Text] [Related]
4. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956 [TBL] [Abstract][Full Text] [Related]
5. Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method. Dralle H; Damm I; Scheumann GF; Kotzerke J; Kupsch E Henry Ford Hosp Med J; 1992; 40(3-4):264-7. PubMed ID: 1362420 [TBL] [Abstract][Full Text] [Related]
6. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E; Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685 [TBL] [Abstract][Full Text] [Related]
7. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma. Gimm O; Ukkat J; Dralle H World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929 [TBL] [Abstract][Full Text] [Related]
8. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
9. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma. Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947 [TBL] [Abstract][Full Text] [Related]
10. Preoperative Clinical and Sonographic Predictors for Lateral Cervical Lymph Node Metastases in Sporadic Medullary Thyroid Carcinoma. Oh HS; Kwon H; Song E; Jeon MJ; Song DE; Kim TY; Lee JH; Hong SJ; Kim WB; Shong YK; Baek JH; Kim WG Thyroid; 2018 Mar; 28(3):362-368. PubMed ID: 29350102 [TBL] [Abstract][Full Text] [Related]
12. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution. Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418 [TBL] [Abstract][Full Text] [Related]
13. [The concept of "microsurgical" technique in medullary thyroid carcinoma]. Mann B; Buhr HJ; Faulhaber J Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():720-3. PubMed ID: 9931710 [TBL] [Abstract][Full Text] [Related]
14. Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Machens A; Gimm O; Ukkat J; Hinze R; Schneyer U; Dralle H Cancer; 2000 Apr; 88(8):1909-15. PubMed ID: 10760769 [TBL] [Abstract][Full Text] [Related]
15. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192 [TBL] [Abstract][Full Text] [Related]
16. Can We Predict the Lateral Compartment Lymph Node Involvement in RET-Negative Patients with Medullary Thyroid Carcinoma? Chandeze MM; Noullet S; Faron M; Trésallet C; Godiris-Petit G; Tissier F; Buffet C; Leenhardt L; Chereau N; Menegaux F Ann Surg Oncol; 2016 Oct; 23(11):3653-3659. PubMed ID: 27271930 [TBL] [Abstract][Full Text] [Related]